Initial Clinical Response Predicts Outcome and Is Associated With Dose Schedule in Metastatic Melanoma and Renal Cell Carcinoma Patients Treated With High-Dose Interleukin 2

被引:0
作者
Kathryn Spanknebel
Kenneth Y. Cheung
John Stoutenburg
Karl Hurst-Wicker
Charles Hesdorffer
Gail DeRaffele RN
and Howard L. Kaufman
机构
[1] Columbia University College of Physicians and Surgeons,Department of Surgery
[2] Columbia University Mailman School of Public Health,Department of Biostatistics
[3] Columbia University College of Physicians and Surgeons,Department of Medicine, Division of Hematology and Oncology
来源
Annals of Surgical Oncology | 2005年 / 12卷
关键词
Melanoma; Renal cell carcinoma; Immunotherapy; Interleukin 2; Metastatic.;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:381 / 390
页数:9
相关论文
共 114 条
[41]  
Dillman RO(undefined)undefined undefined undefined undefined-undefined
[42]  
O’Connor AA(undefined)undefined undefined undefined undefined-undefined
[43]  
Simpson L(undefined)undefined undefined undefined undefined-undefined
[44]  
Barth NM(undefined)undefined undefined undefined undefined-undefined
[45]  
VanderMolen LA(undefined)undefined undefined undefined undefined-undefined
[46]  
Vanderplas P(undefined)undefined undefined undefined undefined-undefined
[47]  
Quan WD(undefined)undefined undefined undefined undefined-undefined
[48]  
Quan FM(undefined)undefined undefined undefined undefined-undefined
[49]  
McDermott D(undefined)undefined undefined undefined undefined-undefined
[50]  
Flaherty L(undefined)undefined undefined undefined undefined-undefined